Triglycerides
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- Longevity-optimal target: below 80 mg/dL. The standard 'normal' of below 150 mg/dL is associated with meaningfully elevated cardiovascular risk compared to the optimal range. Many people in the 100–149 range are told their triglycerides are fine — they aren't optimal.
- Triglycerides are primarily driven by carbohydrate intake, not dietary fat. The biggest lever is reducing refined carbohydrates, sugar, and especially fructose — not necessarily fat restriction.
- The triglyceride-to-HDL ratio is one of the most powerful cardiovascular risk predictors. A ratio above 3.5 (mg/dL) or 1.5 (mmol/L) is strongly associated with insulin resistance and small dense LDL particle predominance.
- High triglycerides are a reliable signal of insulin resistance. Elevated triglycerides and low HDL together are two of the five criteria for metabolic syndrome — both driven by the same underlying carbohydrate-insulin dysfunction.
- Triglycerides respond quickly to intervention. Unlike some biomarkers that take months to shift, triglycerides can drop 30–50% within 2–4 weeks of meaningful dietary change — making them a useful real-time feedback tool.
Triglycerides as a Window Into Metabolic Health
Triglycerides are commonly discussed as a cardiovascular risk factor in the same breath as LDL cholesterol. This framing is accurate but undersells their significance as a metabolic marker. Elevated triglycerides are not just an independent cardiovascular risk factor — they are one of the most reliable indicators of insulin resistance, excess carbohydrate intake, and impaired fat metabolism that a standard blood panel provides.
This matters because the conditions that drive triglycerides up — chronically elevated insulin, excess refined carbohydrate consumption, visceral adiposity, physical inactivity — are the same conditions that drive cardiovascular disease, type 2 diabetes, non-alcoholic fatty liver disease, and cognitive decline. Triglycerides are not merely a downstream cardiovascular risk marker; they are a readout of the entire metabolic environment.
The good news is that triglycerides are among the most responsive biomarkers to intervention. Unlike ApoB or LDL, which often require months to shift meaningfully, triglycerides can fall 30–50% within weeks of dietary change. This makes them an unusually useful real-time feedback signal for assessing whether a metabolic intervention is working.
Standard Reference Ranges vs. Longevity-Optimal Ranges
The current clinical classification of triglycerides identifies "normal" as below 150 mg/dL — a threshold based on the point at which cardiovascular and pancreatitis risk become clinically obvious. It does not represent metabolic optimality. The evidence consistently shows that fasting triglycerides above 80–100 mg/dL are associated with elevated risk even within the "normal" zone.
| Triglycerides (mg/dL) | Standard Classification | Longevity Assessment |
|---|---|---|
| < 80 | Normal | Optimal — excellent metabolic health signal |
| 80–99 | Normal | Good — acceptable, monitor trend |
| 100–149 | Normal | Elevated — lifestyle improvement indicated |
| 150–199 | Borderline high | Concerning — significant metabolic dysfunction likely |
| 200–499 | High | High — aggressive intervention needed |
| ≥ 500 | Very high | Very high — pancreatitis risk; medical evaluation required |
A landmark analysis from the Copenhagen Heart Study found that fasting triglycerides as low as 89 mg/dL were associated with measurably elevated cardiovascular risk compared to levels below 45 mg/dL — suggesting the optimal range is lower than even most longevity-focused clinicians target. 1 The practical longevity target of below 80 mg/dL represents a reasonable, achievable goal for most healthy adults following an optimized diet and exercise program.
Already have your lab results? See how your triglycerides and other markers score on a longevity scale — in under 60 seconds.
Analyze My Biomarkers →Why Carbohydrates Drive Triglycerides More Than Fat Does
The most persistent misconception about triglycerides is that they are driven primarily by dietary fat. This is incorrect — and the confusion leads many people to make the wrong dietary adjustments.
Fasting triglycerides reflect hepatic fat synthesis and VLDL particle output, not direct dietary fat absorption. The primary driver of this process is carbohydrate metabolism — specifically, what happens when carbohydrate intake exceeds the storage capacity of muscle and liver glycogen.
Here is the mechanism: when you eat carbohydrates, they are converted to glucose and either used for immediate energy or stored as glycogen. Glycogen stores are finite — the liver holds roughly 100 grams and muscles another 300–500 grams in a typical adult. When these stores are full and carbohydrate intake continues, the liver converts the excess glucose to fatty acids through a process called de novo lipogenesis. These fatty acids are then assembled into triglycerides and packaged into VLDL particles, which are secreted into the bloodstream — raising fasting triglycerides.
Fructose is a particularly potent driver of this pathway. Unlike glucose, which can be used by essentially every cell in the body, fructose is almost entirely taken up by the liver and converted directly to fat. This is why high consumption of fructose-sweetened beverages (soft drinks, fruit juices, energy drinks) and foods with added high-fructose corn syrup produces some of the highest triglyceride responses of any dietary pattern.
Dietary fat follows a different route. Fat absorbed from the gut is packaged into chylomicrons, which do transiently raise triglycerides after a meal — which is why triglycerides must be measured fasting. But dietary fat does not drive the hepatic VLDL production that elevates fasting triglycerides chronically. This is why low-carbohydrate, higher-fat diets reliably and dramatically lower triglycerides, while low-fat, higher-carbohydrate diets (particularly if the carbohydrates are refined) often raise them.
The Triglyceride-to-HDL Ratio: A Powerful Risk Surrogate
Alone, triglycerides tell an incomplete story. Paired with HDL cholesterol as a ratio, they become one of the most powerful cardiovascular risk predictors available from a standard lipid panel — and a reliable surrogate for LDL particle characteristics that standard panels don't measure.
The connection works through LDL particle biology. When triglycerides are elevated and HDL is low — the classic insulin-resistant dyslipidemia pattern — the LDL particles in circulation tend to be small and dense (pattern B) rather than large and buoyant (pattern A). Small dense LDL particles are significantly more atherogenic: they penetrate arterial walls more readily, oxidize more easily, and are taken up by macrophages at higher rates. This is the lipid pattern most strongly associated with atherosclerosis progression and cardiovascular events.
A standard lipid panel reports LDL cholesterol, which measures the total cholesterol content of LDL particles but says nothing about their size or number. A person with LDL of 120 mg/dL and a triglyceride:HDL ratio of 4.0 likely has predominantly small dense LDL and a much higher atherogenic particle count than their LDL cholesterol implies. A person with LDL of 130 mg/dL and a triglyceride:HDL ratio of 1.2 likely has predominantly large buoyant LDL and a substantially lower actual cardiovascular risk than the higher LDL number might suggest.
| TG:HDL Ratio (mg/dL) | Interpretation | LDL Particle Pattern (likely) |
|---|---|---|
| < 1.0 | Excellent | Predominantly large, buoyant LDL (Pattern A) |
| 1.0–2.0 | Good | Mostly large LDL; some mixed |
| 2.0–3.5 | Elevated risk | Mixed; likely shifting toward small dense |
| > 3.5 | High risk | Predominantly small, dense LDL (Pattern B) |
Calculate your ratio: divide fasting triglycerides (mg/dL) by HDL cholesterol (mg/dL). Both numbers are on any standard lipid panel. This single calculation often reveals more about actual cardiovascular risk than LDL cholesterol alone.
What Raises Triglycerides — and How to Lower Them
Understanding the drivers gives a clear optimization roadmap. Triglycerides are highly responsive to lifestyle, making this one of the most actionable biomarkers in the longevity panel.
Primary drivers of elevated triglycerides
- Sugar and refined carbohydrate excess: The dominant driver. Sugar-sweetened beverages, sweets, refined grains, and ultra-processed foods provide a sustained flood of glucose and fructose that exceeds glycogen storage and drives hepatic fat synthesis.
- Alcohol: Alcohol is metabolized almost exclusively in the liver, where it stimulates fatty acid synthesis and inhibits fatty acid oxidation — directly raising VLDL and triglycerides. Even moderate alcohol consumption (2–3 drinks per day) significantly elevates triglycerides in susceptible individuals.
- Physical inactivity: Exercise increases muscle glycogen storage capacity and triglyceride clearance through lipoprotein lipase activity. Sedentary adults have reduced capacity to clear circulating triglycerides after meals.
- Visceral adiposity: Visceral fat releases free fatty acids into the portal circulation, driving hepatic triglyceride synthesis and VLDL secretion independently of dietary intake.
- Insulin resistance: Insulin normally suppresses hepatic VLDL secretion. When insulin resistance develops, this brake is lost and the liver produces VLDL continuously at a high rate.
- Hypothyroidism: Thyroid hormones are required for LPL activity (the enzyme that clears triglycerides from the blood). Even subclinical hypothyroidism can meaningfully raise triglycerides.
- Certain medications: Beta blockers, thiazide diuretics, corticosteroids, some antipsychotics, and oral estrogen (but not transdermal) can raise triglycerides.
Most effective interventions to lower triglycerides
- Eliminate sugar-sweetened beverages: The single highest-impact dietary change for most people. Soft drinks, fruit juices, energy drinks, and sweetened coffee drinks deliver concentrated fructose directly to the liver's fat synthesis pathway.
- Reduce refined carbohydrates: White bread, pasta, crackers, chips, and packaged foods provide rapidly absorbed glucose that spills over into fat synthesis when consumed in excess of glycogen capacity.
- Aerobic exercise: Both acute exercise and chronic training increase lipoprotein lipase activity, the enzyme that clears triglycerides from the bloodstream. A single bout of aerobic exercise lowers post-meal triglycerides by 20–30%; regular training produces persistent baseline reductions.
- Omega-3 fatty acids: EPA and DHA (from fish oil) at doses of 2–4 grams per day are one of the most consistently effective pharmacological interventions for hypertriglyceridemia, reducing triglycerides by 20–45% in clinical trials. The FDA has approved high-dose prescription omega-3 formulations (Vascepa, Lovaza) specifically for severe hypertriglyceridemia. Over-the-counter fish oil at 3–4 grams EPA+DHA is similarly effective at lower price.
- Reduce or eliminate alcohol: Even cutting alcohol from daily to occasional use produces rapid, significant triglyceride reductions in most individuals.
- Lose visceral fat: Any intervention that reduces abdominal fat reduces the continuous free fatty acid flux to the liver that drives VLDL overproduction.
- Address hypothyroidism: If triglycerides are elevated and TSH is above the optimal range, treating hypothyroidism often normalizes triglycerides without additional dietary intervention.
How to Test Triglycerides
Triglycerides are measured from a standard fasting blood draw and are included in every standard lipid panel. Fasting for 9–12 hours before the draw is required for an interpretable result — post-meal chylomicrons can raise triglycerides by 100+ mg/dL compared to the true fasting baseline.
When reviewing your lipid panel, always note your HDL alongside your triglycerides and calculate the ratio yourself — labs rarely report it, yet it is often more informative than LDL alone.
For a complete cardiovascular picture, pair triglycerides with ApoB — the gold standard for atherogenic particle count. The combination of triglycerides, HDL, and ApoB gives a comprehensive view of both metabolic health and cardiovascular risk that far exceeds what LDL cholesterol alone provides.
Testing frequency: annually as part of a comprehensive metabolic panel for most adults. If actively working to lower elevated triglycerides through dietary or lifestyle changes, a retest at 4–6 weeks provides useful early feedback given how quickly triglycerides respond.
Sources
- Nordestgaard BG, et al. "Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women." JAMA, 2007. PubMed →
- Austin MA, et al. "Hypertriglyceridemia as a Cardiovascular Risk Factor." American Journal of Cardiology, 1998. PubMed →
- Skulas-Ray AC, et al. "Omega-3 Fatty Acids for the Management of Hypertriglyceridemia." Circulation, 2019. PubMed →
| Range Type | Value (mg/dL) | Notes |
|---|---|---|
| Standard Clinical Range | Normal: < 150 mg/dL · Borderline: 150–199 mg/dL · High: 200–499 mg/dL | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | < 80 mg/dL |
Associated with reduced all-cause mortality and extended healthspan.
Studies of populations with the lowest cardiovascular disease rates consistently show fasting triglycerides below 70–80 mg/dL. The standard 'normal' threshold of 150 mg/dL is associated with roughly double the cardiovascular risk of the longevity-optimal target. Levels below 80 mg/dL also reliably indicate good insulin sensitivity and carbohydrate metabolism.
|
Already have your results? See what your Triglycerides and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What is the optimal triglyceride level for longevity?
The longevity-optimal target for fasting triglycerides is below 80 mg/dL. This is considerably lower than the standard clinical cutoff of 150 mg/dL, which was derived to identify elevated risk of pancreatitis and overt dyslipidemia — not to optimize cardiovascular health. Population studies of groups with very low rates of heart disease consistently show fasting triglycerides in the 50–80 mg/dL range. Levels between 80 and 150 mg/dL carry meaningfully elevated cardiovascular and metabolic risk compared to the optimal range, even though they are technically 'normal.' Many longevity clinicians use a level below 100 mg/dL as a minimum acceptable target and below 80 mg/dL as optimal.
Why do carbohydrates raise triglycerides more than fat?
This counterintuitive fact reflects how triglyceride metabolism actually works. When you consume more carbohydrates than your muscles and liver can immediately store as glycogen, the excess is converted to fat (de novo lipogenesis) in the liver and packaged into VLDL particles that raise circulating triglycerides. Fructose is particularly potent at driving this process — it is almost entirely metabolized in the liver and is highly lipogenic. Dietary fat, on the other hand, is packaged into chylomicrons after a meal (which do transiently raise triglycerides) but does not drive the chronic fasting triglyceride elevation associated with carbohydrate excess. People who reduce carbohydrate intake while eating a higher-fat diet typically see dramatic triglyceride reductions.
What is the triglyceride-to-HDL ratio, and why does it matter?
The triglyceride-to-HDL ratio is calculated by dividing your fasting triglycerides by your HDL cholesterol (both in the same units). A ratio below 2.0 (mg/dL) is considered good; below 1.0 is excellent; above 3.5 is a strong signal of insulin resistance and metabolic dysfunction. The ratio matters because it is a reliable surrogate for LDL particle size and number — the metrics that most directly predict atherosclerotic risk but are not measured on a standard lipid panel. When triglycerides are high and HDL is low (the classic pattern of insulin resistance), LDL particles tend to be small and dense, which are more atherogenic than large buoyant LDL particles. A high triglyceride:HDL ratio, even when absolute LDL cholesterol looks acceptable, often indicates a worse actual cardiovascular risk profile than LDL alone suggests.
How quickly can triglycerides be lowered?
Triglycerides are one of the fastest-responding biomarkers to dietary change. In people with elevated triglycerides who reduce refined carbohydrate and sugar intake significantly, reductions of 30–50% are common within 2–4 weeks. Triglycerides are therefore a useful real-time feedback tool: a retest 3–4 weeks after a dietary change gives a reliable early signal of whether the intervention is working. The most effective single intervention is typically eliminating sugar-sweetened beverages, which often contain substantial fructose and directly drive hepatic triglyceride synthesis. Beyond dietary changes, aerobic exercise, weight loss (particularly visceral fat), alcohol reduction, and omega-3 fatty acid supplementation (at doses of 2–4 g EPA+DHA per day) are all well-documented interventions.
Do triglycerides need to be fasting?
Yes — triglycerides must be measured in a fasting state (typically 9–12 hours without food) to be interpretable as a metabolic risk marker. Non-fasting triglycerides are significantly higher due to the chylomicron particles that appear after meals — a value of 200 mg/dL taken 2 hours after eating does not have the same meaning as a fasting value of 200 mg/dL. Some research suggests non-fasting triglycerides actually predict cardiovascular events somewhat better than fasting values, but for standard clinical interpretation and comparison to reference ranges, fasting is required. If you are unsure whether your triglyceride result was fasting, check the sample collection notes on your lab report.